Dr. Peter Gasser, the Principal Investigator (PI) for the MAPS-sponsored LSD/end-of-life anxiety study, issued the first Annual Report discussing the progress weve made in this last year. Were making gradual …
Originally appearing here. Nov 12, 2008 11:28 pm US/Eastern Reporting Derek Valcourt More Information About Study: PDF Study Findings: PDF BALTIMORE (WJZ) • A cancer diagnosis is news no one wants. …
Principal Investigator Peter Gasser MD has enrolled 4 patients in his Swiss LSD/end-of-life anxiety study. On November 3, the second of the patients had an LSD session. On Friday, November 7, MAPS transferred …
The FDA issued a letter saying that we had successfully resolved all the outstanding issues in our Investigative New Drug application (#101,825) to evaluate LSD-assisted psychotherapy in our Swiss end-of-life/anxiety …
By Steven Wishnia Published in AlterNet On Thursday, 25 September, 2008 Originally appearing here. The waves of mass psychedelic utopianism have come and gone, but the hippie movement of the late '60s …
Baltimore Sun July 6, 2008 Editorial Our view: Research with hallucinogens, a trip with a new destination. Originally appearing here. Timothy Leary is smiling somewhere. More than 40 years after the U.S. …
Originally appearing here. A web exclusive piece published online by Newsweek discusses Griffiths’ psilocybin research and his piece containing guidelines for human research with psychedelic compounds, …
During the 1960s, the U.S. Army tested a potent form of synthetic marijuana on soldiers to develop a secret weapon. Meet the Santa Rosa resident who ran the program By Martin A. Lee Published by Bohemian.com …
The basic balance sheet information for FY 2007-2008 is presented below. For a complete discussion of MAPS 2007-2008 fiscal year see Rick Doblin's financial report in MAPS Bulletin Volume 18 number …
By Virginia Prescott Published on Thursday, June 12, 2008. Virginia Prescott with New Hampshire Public Radio interviews freelance writer Peter Bebergal who is based in Cambridge, Mass., and wrote about …
Dear Editor, The obituary for Albert Hofmann, the inventor of LSD who died April 29 at age 102, reported that LSD research was stopped in the early 1970s and never resumed. Actually, a protocol evaluating …
Another short audio clip about Albert Hofmann and his ‘Problem Child’ (MP3) from NPR.
